NanoString Technologies, Inc. (NSTGQ)

0.0990 -0.0085 (-7.91%) At close: 03:55PM EDT

NanoString Technologies, Inc.

530 Fairview Avenue North
Seattle, WA 98109
United States
206 378 6266
https://www.nanostring.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 550

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. R. Bradley Gray	CEO, President & Director	1.06M	N/A	1977
Mr. K. Thomas Bailey M.B.A.	Chief Financial Officer	637.41k	N/A	1969
Dr. Joseph M. Beechem Ph.D.	Chief Scientific Officer and Senior VP of Research & Development	637.41k	N/A	1958
Mr. Mark A. Winham	Senior Vice President of Operations	N/A	N/A	N/A
Mr. Douglas S. Farrell	Vice President of Investor Relations & Corporate Communications	N/A	N/A	N/A
Ms. Kathryn Surace-Smith	Senior VP of Human Resources & Legal Affairs and Corporate Secretary	N/A	N/A	1959
Elizabeth Schneider Ph.D.	Senior Global Marketing Manager	N/A	N/A	N/A
Dr. Philippa Webster Ph.D.	Senior Principal Scientist	N/A	N/A	N/A
Mr. Todd Garland	Chief Commercial Officer	N/A	N/A	1970
Praveer Sharma	Field Application Scientist	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Corporate Governance

NanoString Technologies, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 9. The pillar scores are Audit: 8; Board: 5; Shareholder Rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.